Mark V. Pinti
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Clinical Biochemistry top 10%
Papers in
-
- RNA modifications and cancer 6
- Mitochondrial Function and Pathology 5
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 4
- Co-authors
- John M. Hollander (23 shared papers)Quincy A. Hathaway (17 shared papers)Andrya J. Durr (12 shared papers)Amina Kunovac (12 shared papers)Garrett K. Fink (6 shared papers)Danielle L. Shepherd (8 shared papers)C.E. Nichols (5 shared papers)Timothy R. Nurkiewicz (5 shared papers)
- Journals
- American Journal of Physiology-Heart and Circulatory Physiology (5 papers)Particle and Fibre Toxicology (3 papers)Nanotoxicology (2 papers)Journal of Molecular and Cellular Cardiology (2 papers)Experimental Neurology (2 papers)
- Partner nations
- United StatesJapan
In The Last Decade
Mark V. Pinti
25 papers receiving 1.0k citations
Mark V. Pinti's Hit Papers
Peers
Comparison fields: 5 of 108
- Cancer Research 177
- Clinical Biochemistry 55
- Molecular Biology 470
- Physiology 141
- Health, Toxicology and Mutagenesis 79
Countries citing papers authored by Mark V. Pinti
This map shows the geographic impact of Mark V. Pinti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark V. Pinti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark V. Pinti more than expected).
Fields of papers citing papers by Mark V. Pinti
This network shows the impact of papers produced by Mark V. Pinti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark V. Pinti. The network helps show where Mark V. Pinti may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark V. Pinti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis Hit paper breakdown → | 2019 | 308 |
| 2 | 2018 | 108 | |
| 3 | 2017 | 72 | |
| 4 | 2019 | 69 | |
| 5 | 2017 | 51 | |
| 6 | 2016 | 50 | |
| 7 | 2016 | 48 | |
| 8 | 2019 | 41 | |
| 9 | 2018 | 36 | |
| 10 | 2019 | 24 | |
| 11 | 2019 | 23 | |
| 12 | 2022 | 23 | |
| 13 | 2020 | 22 | |
| 14 | 2018 | 20 | |
| 15 | 2021 | 19 | |
| 16 | 2021 | 17 | |
| 17 | 2021 | 16 | |
| 18 | 2020 | 15 | |
| 19 | 2021 | 14 | |
| 20 | 2021 | 12 |
About Mark V. Pinti
Mark V. Pinti is a scholar working on Molecular Biology, Cancer Research, Neurology, Pulmonary and Respiratory Medicine and Health, Toxicology and Mutagenesis, having authored 26 papers that have together received 1.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), RNA modifications and cancer (6 papers), Mitochondrial Function and Pathology (5 papers), Cancer-related molecular mechanisms research (4 papers), Traumatic Brain Injury and Neurovascular Disturbances (2 papers), Metabolism and Genetic Disorders (2 papers), Nanoparticles: synthesis and applications (2 papers) and Air Quality and Health Impacts (2 papers). The work is most often cited by research in Cancer Research (177 citations), Clinical Biochemistry (55 citations), Molecular Biology (470 citations), Physiology (141 citations) and Health, Toxicology and Mutagenesis (79 citations). Mark V. Pinti has collaborated with scholars based in United States and Japan. Frequent co-authors include John M. Hollander, Quincy A. Hathaway, Andrya J. Durr, Amina Kunovac, Garrett K. Fink, Danielle L. Shepherd, C.E. Nichols, Timothy R. Nurkiewicz, Andrew D. Taylor and Pushkar Saralkar. Their work appears in journals such as American Journal of Physiology-Heart and Circulatory Physiology, Particle and Fibre Toxicology, Nanotoxicology, Journal of Molecular and Cellular Cardiology and Experimental Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.